EU Extends Pilot Of New Drug Safety Reporting System
Testing of the enhanced EU drug safety reporting system, EudraVigilance, is to be extended beyond February in an effort to gain more information on how stakeholders are finding the new requirements.
You may also be interested in...
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The pilot phase of a European project on new safety signal notification requirements has been extended for a second time following inconclusive results.